<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Nephrol</journal-id><journal-id journal-id-type="iso-abbrev">BMC Nephrol</journal-id><journal-title-group><journal-title>BMC Nephrology</journal-title></journal-title-group><issn pub-type="epub">1471-2369</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26248851</article-id><article-id pub-id-type="pmc">4528362</article-id><article-id pub-id-type="publisher-id">80</article-id><article-id pub-id-type="doi">10.1186/s12882-015-0080-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Update: Rationale and design of the <italic>So</italic>dium <italic>L</italic>owering <italic>I</italic>n <italic>D</italic>ialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dunlop</surname><given-names>Joanna Leigh</given-names></name><address><email>Joanna.Dunlop@middlemore.co.nz</email><email>jdun218@aucklanduni.ac.nz</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Vandal</surname><given-names>Alain Charles</given-names></name><address><email>alain.vandal@aut.ac.nz</email></address><xref ref-type="aff" rid="Aff3"/><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author"><name><surname>de Zoysa</surname><given-names>Janak Rashme</given-names></name><address><email>Janak.deZoysa@waitematadhb.govt.nz</email></address><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author"><name><surname>Gabriel</surname><given-names>Ruvin Sampath</given-names></name><address><email>ruvin.gabriel@middlemore.co.nz</email></address><xref ref-type="aff" rid="Aff6"/></contrib><contrib contrib-type="author"><name><surname>Haloob</surname><given-names>Imad Adbi</given-names></name><address><email>ihaloob@gmail.coml</email></address><xref ref-type="aff" rid="Aff7"/></contrib><contrib contrib-type="author"><name><surname>Hood</surname><given-names>Christopher John</given-names></name><address><email>Chris.Hood@middlemore.co.nz</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Matheson</surname><given-names>Philip James</given-names></name><address><email>philip.Matheson@ccdhb.org.nz</email></address><xref ref-type="aff" rid="Aff8"/></contrib><contrib contrib-type="author"><name><surname>McGregor</surname><given-names>David Owen Ross</given-names></name><address><email>David.McGregor@cdhb.govt.nz</email></address><xref ref-type="aff" rid="Aff9"/></contrib><contrib contrib-type="author"><name><surname>Rabindranath</surname><given-names>Kannaiyan Samuel</given-names></name><address><email>K.Rabindranath@waikatodhb.health.nz</email></address><xref ref-type="aff" rid="Aff10"/></contrib><contrib contrib-type="author"><name><surname>Semple</surname><given-names>David John</given-names></name><address><email>DSemple@adhb.govt.nz</email></address><xref ref-type="aff" rid="Aff11"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Marshall</surname><given-names>Mark Roger</given-names></name><address><email>mrmarsh@woosh.co.nz</email><email>mmar024@aucklanduni.ac.nz</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/><xref ref-type="aff" rid="Aff12"/></contrib><aff id="Aff1"><label/>Auckland Clinical School, Faculty of Medical and Health Sciences, University of Auckland, Private Bag 93311, Otahuhu, Auckland 1640 New Zealand </aff><aff id="Aff2"><label/>Department of Renal Medicine, Middlemore Hospital, Counties Manukau District Health Board, Private Bag 93311, Otahuhu, Auckland 1640 New Zealand </aff><aff id="Aff3"><label/>Faculty of Health and Environmental Sciences, Auckland University of Technology, North Shore Campus, Private Bag 92006, Auckland, 1142 New Zealand </aff><aff id="Aff4"><label/>Ko Awatea, Middlemore Hospital, Counties Manukau District Health Board, Private Bag 93311, Otahuhu, Auckland 1640 New Zealand </aff><aff id="Aff5"><label/>Renal Service, North Shore Hospital, Waitemata District Health Board, Private Bag 93503, Takapuna, Auckland 0740 New Zealand </aff><aff id="Aff6"><label/>Department of Cardiology, Middlemore Hospital, Counties Manukau District Health Board, Private Bag 93311, Otahuhu, Auckland 1640 New Zealand </aff><aff id="Aff7"><label/>Bathurst Health Service, New South Wales, Australia </aff><aff id="Aff8"><label/>Department of Nephrology, Wellington Hospital, Capital &#x00026; Coast District Health Board, Private Bag 7902, Wellington South, New Zealand </aff><aff id="Aff9"><label/>Department of Nephrology, Christchurch Hospital, Canterbury District Health Board, Private Bag 4710, Christchurch, New Zealand </aff><aff id="Aff10"><label/>Department of Renal Medicine, Waikato Hospital, Waikato District Health Board, Private Bag 3200, Hamilton, 3240 New Zealand </aff><aff id="Aff11"><label/>Department of Renal Medicine, Auckland City Hospital, Auckland District Health Board, Private Bag 92024, Auckland, Auckland 0740 New Zealand </aff><aff id="Aff12"><label/>Medical Affairs - Renal (Asia Pacific), Baxter Healthcare, P.O. Box 14062, Panmure, Auckland 1741 New Zealand </aff></contrib-group><pub-date pub-type="epub"><day>1</day><month>8</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>8</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>16</volume><elocation-id>120</elocation-id><history><date date-type="received"><day>11</day><month>2</month><year>2015</year></date><date date-type="accepted"><day>11</day><month>2</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; Dunlop et al. 2015</copyright-statement><license license-type="open-access"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><p>After the publication of our paper Dunlop et al. &#x0201c;Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass&#x0201d;, we became aware of further data correlating left ventricular (LV) mass index at baseline and their correpsonding mass at 12&#x000a0;months, using cardiac margnetic resonanace imaging (MRI) in patients on hemodialysis. The original published sample size for the SoLID trial of 118 was a conservative estimate, calculated using analysis of covariance and a within person Pearson&#x02019;s correlation for LV mass index of 0.75. New data communicated to the SoLID trial group has resulted in re-calcuation of the sample size, based upon a within person Pearson&#x02019;s correlation of 0.8 but otherwise unchanged assumptions. As a result, the SoLID trial will now recruit 96 participants.</p></abstract><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Update</title><p>After the publication of our paper Dunlop et al. &#x0201c;Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass&#x0201d; [<xref ref-type="bibr" rid="CR1">1</xref>], we became aware of further data correlating left ventricular (LV) mass index at baseline and their correpsonding mass at 12&#x000a0;months, using cardiac margnetic resonanace imaging (MRI) in patients on hemodialysis.</p><p>The original published sample size for the SoLID trial of 118 was a conservative estimate, calculated using repeated-measures analysis of covariance (ANCOVA) and a within person Pearson&#x02019;s correlation for LV mass index of 0.75. The assumption of a correlation of 0.75 was based on private communication from the Jardine group (private communication P Mark 8/2/2011) [<xref ref-type="bibr" rid="CR2">2</xref>&#x02013;<xref ref-type="bibr" rid="CR4">4</xref>]: in a cohort of 59 patients of their patients with repeated measures of LVMI at least 6&#x000a0;months apart (using cardiac MRI), correlation was 0.87 (p&#x02009;&#x0003c;&#x02009;0.001) with normally distributed data. Modelling these data, and allowing for 25&#x000a0;% for drop outs, it was determined that 59 participants would be enrolled in each arm (power 0.8, alpha 0.05).</p><p>New data communicated to the SoLID trial group has resulted in us re-calculating sample size for the SoLID trial (private communication C McIntyre and A Odudu 30/4/2014) [<xref ref-type="bibr" rid="CR5">5</xref>]: in a cohort of 44 patients of their patients with repeated measures of LV mass index 12&#x000a0;months apart (using cardiac MRI), correlation was 0.81 (p&#x02009;&#x0003c;&#x02009;0.001). In 21 of these patients, there was an intervention that might have modestly affected their LV mass index; however, restricting analysis to the 23 paired values in the control group provides a similar correlation of 0.83.</p><p>Based on the data above, the sample size has been recalculated using a within person correlation of 0.8, but otherwise unchanged assumptions. It is was determined that 48 participants will be enrolled in each arm. The change in sample size has been approved by the National (New Zealand) Multi-region Ethics Committee (IRB00004663) of the New Zealand Ministry of Health (IORG0000895), and the primary funding body for this study the Health Research Council of New Zealand.</p></sec></body><back><fn-group><fn><p>The online version of the original article can be found under doi:10.1186/1471-2369-14-149.</p></fn><fn><p><bold>Competing interests</bold></p><p>The authors declare that they have no competing interests.</p></fn><fn><p><bold>Authors&#x02019; contributions</bold></p><p>JLD participated in the trial design, and drafted the manuscript. ACV participated in the trial design, developed the statistical plan, and helped to draft the manuscript. MRM conceived and developed the trial, and participated in the statistical plan and helped to draft the manuscript. RSG, IAH, and DORM participated in design and development of the trial, and helped to draft the manuscript. JRdZ and PJM participated in the trial design and coordination, and helped to draft the manuscript. CJH, KSR, and DJS participated in the trial coordination and implementation, and helped to draft the manuscript. All authors read and approved the final manuscript.</p></fn><fn><p><bold>Acknowledgments</bold></p><p>The SoLID trial is funded through grants from the Health Research Council of New Zealand, the Maurice and Phyllis Paykel Trust and the Royal Australasian College of Physicians (RACP) Research Foundation. JLD is a current recipient of an RACP Jacquot Research Entry Scholarship, and MRM is a current recipient of an RACP Jacquot Research Establishment Fellowships. The SoLID trial research team would like to acknowledge the kindness of the Jacquot Family in supporting nephrological research in Australasia, and the kindness of Mr and Mrs Kwun Kwok and their son Mr Siu Hang Kok for supporting nephrological research at Counties Manukau District Health Board. The SoLID trial research team would also like to acknowledge the Australasian Kidney Trial Network (<ext-link ext-link-type="uri" xlink:href="http://www.aktn.org.au">http://www.aktn.org.au</ext-link>), for providing advice and assistance on the design of the trial.</p></fn></fn-group><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunlop</surname><given-names>JL</given-names></name><name><surname>Vandal</surname><given-names>AC</given-names></name><name><surname>de Zoysa</surname><given-names>JR</given-names></name><name><surname>Gabriel</surname><given-names>RS</given-names></name><name><surname>Haloob</surname><given-names>IA</given-names></name><name><surname>Hood</surname><given-names>CJ</given-names></name><name><surname>Matheson</surname><given-names>PJ</given-names></name><name><surname>McGregor</surname><given-names>DO</given-names></name><name><surname>Rabindranath</surname><given-names>KS</given-names></name><name><surname>Semple</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass</article-title><source>BMC Nephrol</source><year>2013</year><volume>14</volume><fpage>149</fpage><pub-id pub-id-type="doi">10.1186/1471-2369-14-149</pub-id><pub-id pub-id-type="pmid">23855560</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mark</surname><given-names>PB</given-names></name><name><surname>Patel</surname><given-names>RK</given-names></name><name><surname>Jardine</surname><given-names>AG</given-names></name></person-group><article-title>Are we overestimating left ventricular abnormalities in end-stage renal disease?</article-title><source>Nephrol Dial Transplant</source><year>2007</year><volume>22</volume><issue>7</issue><fpage>1815</fpage><lpage>1819</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfm224</pub-id><pub-id pub-id-type="pmid">17438003</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>RK</given-names></name><name><surname>Jardine</surname><given-names>AG</given-names></name><name><surname>Mark</surname><given-names>PB</given-names></name><name><surname>Cunningham</surname><given-names>AF</given-names></name><name><surname>Steedman</surname><given-names>T</given-names></name><name><surname>Powell</surname><given-names>JR</given-names></name><name><surname>McQuarrie</surname><given-names>EP</given-names></name><name><surname>Stevens</surname><given-names>KK</given-names></name><name><surname>Dargie</surname><given-names>HJ</given-names></name></person-group><article-title>Association of left atrial volume with mortality among ESRD patients with left ventricular hypertrophy referred for kidney transplantation</article-title><source>Am J Kidney Dis</source><year>2010</year><volume>55</volume><issue>6</issue><fpage>1088</fpage><lpage>1096</lpage><pub-id pub-id-type="doi">10.1053/j.ajkd.2009.12.033</pub-id><pub-id pub-id-type="pmid">20346559</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>RK</given-names></name><name><surname>Oliver</surname><given-names>S</given-names></name><name><surname>Mark</surname><given-names>PB</given-names></name><name><surname>Powell</surname><given-names>JR</given-names></name><name><surname>McQuarrie</surname><given-names>EP</given-names></name><name><surname>Traynor</surname><given-names>JP</given-names></name><name><surname>Dargie</surname><given-names>HJ</given-names></name><name><surname>Jardine</surname><given-names>AG</given-names></name></person-group><article-title>Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging</article-title><source>Clin J Am Soc Nephrol</source><year>2009</year><volume>4</volume><issue>9</issue><fpage>1477</fpage><lpage>1483</lpage><pub-id pub-id-type="doi">10.2215/CJN.03350509</pub-id><pub-id pub-id-type="pmid">19713289</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odudu</surname><given-names>A</given-names></name><name><surname>Eldehni</surname><given-names>MT</given-names></name><name><surname>Fakis</surname><given-names>A</given-names></name><name><surname>McIntyre</surname><given-names>CW</given-names></name></person-group><article-title>Rationale and design of a multi-centre randomised controlled trial of individualised cooled dialysate to prevent left ventricular systolic dysfunction in haemodialysis patients</article-title><source>BMC Nephrol</source><year>2012</year><volume>13</volume><fpage>45</fpage><pub-id pub-id-type="doi">10.1186/1471-2369-13-45</pub-id><pub-id pub-id-type="pmid">22720738</pub-id></element-citation></ref></ref-list></back></article>